Trials / Unknown
UnknownNCT01773915
New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
Alzheimer's disease (AD) is the most common neurodegenerative disorder afflicting the elderly. Currently, some biochemical tests performed on Cerebrospinal Fluid (CSF) samples have demonstrated to discriminate to some extend between AD and non-AD individuals based on the levels of tau, phospho-tau or Aβ42. We aim to investigate newly identified proteins whose levels increase during the Braak Stages of AD that are accessible in other body fluids such as blood, urine or saliva. The detection of these proteins would allow performing simple tests in case its levels were confirmed to be associated with the AD pathology.
Detailed description
We do not desire to provide a more extensive description
Conditions
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2014-01-01
- Completion
- 2014-06-01
- First posted
- 2013-01-23
- Last updated
- 2014-01-14
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01773915. Inclusion in this directory is not an endorsement.